PL356766A1 - Stabilne sole nowoczesnych pochodnych 3,3-difenylopropyloamin - Google Patents

Stabilne sole nowoczesnych pochodnych 3,3-difenylopropyloamin

Info

Publication number: PL356766A1
Authority: PL; Poland
Prior art keywords: new; diphenylpropylamines; novel derivatives; stable salts; salts
Prior art date: 1999-11-16

Application number

PL00356766A

Other languages

English (en)

Other versions

PL201422B1 (pl

Inventor

Claus Meese

Original Assignee

Schwarz Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-16

Filing date

2000-11-15

Publication date

2004-07-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7929277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL356766(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-11-15 Application filed by Schwarz Pharma Ag filed Critical Schwarz Pharma Ag

2004-07-12 Publication of PL356766A1 publication Critical patent/PL356766A1/pl

2009-04-30 Publication of PL201422B1 publication Critical patent/PL201422B1/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Catalysts (AREA)
Detergent Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Luminescent Compositions (AREA)

PL356766A 1999-11-16 2000-11-15 Stabilna sól izomaślanu R-(+)-2-(3-(diizopropyloamino-1-fenylopropylo)-4-hydroksymetylofenylowego PL201422B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19955190A DE19955190A1 (de)	1999-11-16	1999-11-16	Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen
PCT/EP2000/011309 WO2001035957A1 (de)	1999-11-16	2000-11-15	Stabile salze neuartiger derivate von 3,3-diphenylpropylaminen

Publications (2)

Publication Number	Publication Date
PL356766A1 true PL356766A1 (pl)	2004-07-12
PL201422B1 PL201422B1 (pl)	2009-04-30

Family

ID=7929277

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL356766A PL201422B1 (pl)	1999-11-16	2000-11-15	Stabilna sól izomaślanu R-(+)-2-(3-(diizopropyloamino-1-fenylopropylo)-4-hydroksymetylofenylowego

Country Status (30)

Country	Link
US (1)	US6858650B1 (pl)
EP (3)	EP1230209B3 (pl)
JP (6)	JP4083431B2 (pl)
KR (2)	KR100563149B1 (pl)
CN (1)	CN1215045C (pl)
AT (3)	ATE286872T1 (pl)
AU (1)	AU778132B2 (pl)
BR (1)	BRPI0015610C1 (pl)
CA (1)	CA2389749C (pl)
CY (2)	CY1106204T1 (pl)
CZ (2)	CZ302497B6 (pl)
DE (5)	DE29923134U1 (pl)
DK (3)	DK1481964T3 (pl)
EA (1)	EA005588B1 (pl)
ES (3)	ES2236032T7 (pl)
GE (1)	GEP20084430B (pl)
HK (3)	HK1067114A1 (pl)
HU (2)	HU228197B1 (pl)
IL (2)	IL149567A0 (pl)
IS (2)	IS2124B (pl)
MX (1)	MXPA02004603A (pl)
NO (2)	NO323920B1 (pl)
NZ (1)	NZ519230A (pl)
PL (1)	PL201422B1 (pl)
PT (3)	PT1481964E (pl)
SI (3)	SI1481964T1 (pl)
SK (3)	SK287430B6 (pl)
UA (2)	UA73324C2 (pl)
WO (1)	WO2001035957A1 (pl)
ZA (1)	ZA200203315B (pl)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0957073A1 (en) *	1998-05-12	1999-11-17	Schwarz Pharma Ag	Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) *	1999-11-16	2000-06-29	Schwarz Pharma Ag, 40789 Monheim	Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen
DE10028443C1 (de) *	2000-06-14	2002-05-29	Sanol Arznei Schwarz Gmbh	Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
DE10315917A1 (de) *	2003-04-08	2004-11-18	Schwarz Pharma Ag	Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
DE10315878B4 (de)	2003-04-08	2009-06-04	Schwarz Pharma Ag	Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung
WO2005012227A2 (en) *	2003-08-05	2005-02-10	Ranbaxy Laboratories Limited	Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
ES2235648B1 (es) *	2003-12-22	2006-11-01	Ragactives, S.L.	Procedimiento para la obtencion de tolterodina.
US8034823B2 (en) *	2005-02-22	2011-10-11	Savvipharm Inc	Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
KR100647068B1 (ko)	2005-09-15	2006-11-23	하나제약 주식회사	라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
ATE480531T1 (de) *	2006-05-24	2010-09-15	Pfizer Ltd	Verfahren zur herstellung von benzopyran-2- olderivaten
BRPI0711881B1 (pt)	2006-05-31	2016-09-27	Schwarz Pharma Ltd	síntese de hidroximetil fenóis substituídos
EP1862449A1 (en) *	2006-05-31	2007-12-05	Schwarz Pharma Ltd.	A shortened synthesis of substituted hydroxymethyl phenols
IES20060424A2 (en) *	2006-06-08	2007-10-31	Schwarz Pharma Ltd	Accelerated synthesis of (3-Diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol and its phenolic monoesters
PE20080331A1 (es) *	2006-06-09	2008-06-19	Sanol Arznei Schwarz Gmbh	Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
CA2648333C (en) *	2006-06-09	2014-04-29	Schwarz Pharma Ltd	Synthesis of phenolic esters of hydroxymethyl phenols
US7807715B2 (en)	2006-06-09	2010-10-05	Ucb Pharma Gmbh	Pharmaceutical compositions comprising fesoterodine
IES20060435A2 (en) *	2006-06-12	2007-12-12	Schwarz Pharma Ltd	Shortened synthesis using paraformaldehyde or trioxane
KR20140010198A (ko)	2006-06-12	2014-01-23	유씨비 파마 게엠베하	새로운 키랄 중간체, 그 키랄 중간체의 제조방법 및 톨테로딘, 페소테로딘 또는 그 활성대사물질의 제조에서 그 키랄 중간체의 사용
US20100217034A1 (en) *	2007-09-21	2010-08-26	Actavis Group Ptc Ehf	Process for the Preparation of Fesoterodine
US20100297241A1 (en) *	2007-10-01	2010-11-25	Actavis Group Ptc Ehf	Amorphous Fesoterodine Fumarate
WO2009122303A2 (en) *	2008-04-04	2009-10-08	Actavis Group Ptc Ehf	Novel mandelate salt of fesoterodine
WO2010010464A2 (en) *	2008-07-21	2010-01-28	Actavis Group Ptc Ehf	Fesoterodine substantially free of dehydroxy impurity
IT1392082B1 (it) *	2008-12-10	2012-02-09	Chemi Spa	Nuove forme solide della fesoterodina fumarato
US9085507B2 (en)	2009-05-11	2015-07-21	Ratiopharm Gmbh	Desfesoterodine in the form of a tartaric acid salt
IT1394217B1 (it) *	2009-05-15	2012-06-01	Chemi Spa	Metodo di preparazione di fesoterodina e/o fesoterodina fumarato.
IT1394219B1 (it)	2009-05-15	2012-06-01	Chemi Spa	Metodo di preparazione di fesoterodina fumarato di elevata purezza.
WO2011029005A1 (en)	2009-09-03	2011-03-10	Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag	Crystalline forms of fesoterodine fumarate and fesoterodine base
IT1396373B1 (it) *	2009-10-29	2012-11-19	Dipharma Francis Srl	Procedimento per la preparazione di fesoterodina.
EP2316432A1 (de)	2009-10-30	2011-05-04	ratiopharm GmbH	Zusammensetzung enthaltend Fesoterodin und Ballaststoffe
US20110124903A1 (en) *	2009-11-20	2011-05-26	Actavis Group Ptc Ehf	Solid state forms of fesoterodine intermediates
IT1397521B1 (it) *	2009-12-21	2013-01-16	Dipharma Francis Srl	Procedimento per la preparazione di fesoterodina con un basso contenuto di impurezze.
IT1397920B1 (it) *	2010-02-08	2013-02-04	Dipharma Francis Srl	Forma cristallina di fesoterodina fumarato e procedimento per la sua preparazione
EP2549985A1 (en)	2010-03-22	2013-01-30	Cadila Healthcare Limited	Stable pharmaceutical compositions comprising fesoterodine
CA2796877A1 (en)	2010-04-30	2011-11-03	Merck Sharp & Dohme Corp.	Novel beta 3 adrenergic receptor agonists
WO2011141932A2 (en)	2010-05-11	2011-11-17	Intas Pharmaceuticals Limited	Process for preparation of phenolic monoesters of hydroxymethyl phenols
WO2011145019A1 (en) *	2010-05-17	2011-11-24	Orchid Chemicals And Pharmaceuticals Limited	Improved process for diphenylpropylamine derivatives
IT1401451B1 (it)	2010-06-10	2013-07-26	Chemi Spa	Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
WO2011158257A1 (en)	2010-06-18	2011-12-22	Panacea Biotec Ltd	Preparation process of fesoterodine and intermediates
US9012678B2 (en) *	2010-08-25	2015-04-21	Cadila Healthcare Limited	Processes for the preparation of fesoterodine
IT1403094B1 (it)	2010-12-09	2013-10-04	Dipharma Francis Srl	Procedimento per la preparazione di fesoterodina o un suo sale
WO2012098560A2 (en) *	2011-01-17	2012-07-26	Msn Laboratories Limited	Process for the preparation of muscarinic receptor antagonist
TWI590821B (zh)	2011-01-18	2017-07-11	輝瑞有限公司	固體分子分散液
EP2508175A1 (en)	2011-04-08	2012-10-10	LEK Pharmaceuticals d.d.	Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
EP2508173A1 (en)	2011-04-08	2012-10-10	LEK Pharmaceuticals d.d.	Stabilized pharmaceutical composition comprising fesoterodine
US9422228B2 (en)	2012-05-04	2016-08-23	Crystal Pharma, S.A.U.	Process for the preparation of optically pure fesoterodine derivatives
ITMI20121232A1 (it)	2012-07-16	2014-01-17	Cambrex Profarmaco Milano Srl	Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
TR201721437A2 (tr)	2017-12-25	2019-07-22	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
EP4237405A1 (en) *	2020-10-27	2023-09-06	Wella Germany GmbH	2-methoxymethyl-p-phenylenediamine in cosmetic grade quality

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR75395B (pl) *	1980-11-14	1984-07-13	Lilly Co Eli
IL66831A0 (en) *	1981-10-05	1982-12-31	Kefalas As	Indane derivatives
SE8800207D0 (sv) *	1988-01-22	1988-01-22	Kabivitrum Ab	Nya aminer, deras anvendning och framstellning
IE910752A1 (en) *	1990-03-08	1991-09-11	Fujisawa Pharmaceutical Co	A novel substituted-amine compound and a process for the¹preparation thereof
JPH0483431A (ja) *	1990-07-26	1992-03-17	Seiko Epson Corp	選択呼出受信機
SE9203318D0 (sv) *	1992-11-06	1992-11-06	Kabi Pharmacia Ab	Novel 3,3-diphenylpropylamines, their use and preparation
SE9701144D0 (sv) *	1997-03-27	1997-03-27	Pharmacia & Upjohn Ab	Novel compounds, their use and preparation
EP0957073A1 (en) *	1998-05-12	1999-11-17	Schwarz Pharma Ag	Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) *	1999-11-16	2000-06-29	Schwarz Pharma Ag, 40789 Monheim	Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen

1999
- 1999-11-16 DE DE29923134U patent/DE29923134U1/de not_active Expired - Lifetime
- 1999-11-16 DE DE19955190A patent/DE19955190A1/de not_active Ceased
2000
- 2000-11-15 CZ CZ20060247A patent/CZ302497B6/cs not_active IP Right Cessation
- 2000-11-15 PT PT04018487T patent/PT1481964E/pt unknown
- 2000-11-15 DE DE50009239T patent/DE50009239D1/de not_active Expired - Lifetime
- 2000-11-15 UA UA2002043609A patent/UA73324C2/uk unknown
- 2000-11-15 HU HU0204034A patent/HU228197B1/hu unknown
- 2000-11-15 KR KR1020057018318A patent/KR100563149B1/ko active IP Right Grant
- 2000-11-15 DK DK04018487T patent/DK1481964T3/da active
- 2000-11-15 DK DK00989857T patent/DK1230209T3/da active
- 2000-11-15 SI SI200030890T patent/SI1481964T1/sl unknown
- 2000-11-15 EP EP00989857A patent/EP1230209B3/de not_active Expired - Lifetime
- 2000-11-15 EP EP06011207A patent/EP1690536B1/de not_active Expired - Lifetime
- 2000-11-15 DE DE50013365T patent/DE50013365D1/de not_active Expired - Lifetime
- 2000-11-15 PT PT06011207T patent/PT1690536E/pt unknown
- 2000-11-15 CA CA002389749A patent/CA2389749C/en not_active Expired - Lifetime
- 2000-11-15 SK SK657-2002A patent/SK287430B6/sk not_active IP Right Cessation
- 2000-11-15 SI SI200030617T patent/SI1230209T1/xx unknown
- 2000-11-15 CN CNB008157057A patent/CN1215045C/zh not_active Expired - Lifetime
- 2000-11-15 ES ES00989857T patent/ES2236032T7/es active Active
- 2000-11-15 DE DE50015163T patent/DE50015163D1/de not_active Expired - Lifetime
- 2000-11-15 AT AT00989857T patent/ATE286872T1/de active
- 2000-11-15 WO PCT/EP2000/011309 patent/WO2001035957A1/de active Application Filing
- 2000-11-15 US US10/130,214 patent/US6858650B1/en not_active Expired - Lifetime
- 2000-11-15 BR BRPI0015610A patent/BRPI0015610C1/pt not_active IP Right Cessation
- 2000-11-15 ES ES06011207T patent/ES2303708T3/es not_active Expired - Lifetime
- 2000-11-15 EA EA200200511A patent/EA005588B1/ru not_active IP Right Cessation
- 2000-11-15 AT AT04018487T patent/ATE337293T1/de active
- 2000-11-15 CZ CZ20021343A patent/CZ302967B6/cs not_active IP Right Cessation
- 2000-11-15 KR KR10-2002-7006306A patent/KR100536095B1/ko not_active IP Right Cessation
- 2000-11-15 ES ES04018487T patent/ES2270240T3/es not_active Expired - Lifetime
- 2000-11-15 DK DK06011207T patent/DK1690536T3/da active
- 2000-11-15 EP EP04018487A patent/EP1481964B1/de not_active Expired - Lifetime
- 2000-11-15 IL IL14956700A patent/IL149567A0/xx unknown
- 2000-11-15 NZ NZ519230A patent/NZ519230A/en not_active IP Right Cessation
- 2000-11-15 AT AT06011207T patent/ATE395056T1/de active
- 2000-11-15 JP JP2001537950A patent/JP4083431B2/ja not_active Expired - Lifetime
- 2000-11-15 SK SK5024-2013A patent/SK288384B6/sk not_active IP Right Cessation
- 2000-11-15 PL PL356766A patent/PL201422B1/pl unknown
- 2000-11-15 PT PT00989857T patent/PT1230209E/pt unknown
- 2000-11-15 MX MXPA02004603A patent/MXPA02004603A/es active IP Right Grant
- 2000-11-15 AU AU26667/01A patent/AU778132B2/en not_active Expired
- 2000-11-15 HU HU0900587A patent/HU227608B1/hu unknown
- 2000-11-15 SK SK5027-2010A patent/SK288185B6/sk not_active IP Right Cessation
- 2000-11-15 SI SI200030998T patent/SI1690536T1/sl unknown
2002
- 2002-04-19 IS IS6351A patent/IS2124B/xx unknown
- 2002-04-25 ZA ZA200203315A patent/ZA200203315B/xx unknown
- 2002-05-09 IL IL149567A patent/IL149567A/en active IP Right Grant
- 2002-05-15 NO NO20022314A patent/NO323920B1/no not_active IP Right Cessation
- 2002-09-05 HK HK04110231A patent/HK1067114A1/xx not_active IP Right Cessation
- 2002-09-05 HK HK02106545.5A patent/HK1045148B/zh not_active IP Right Cessation
2005
- 2005-01-17 UA UAA200500434A patent/UA77322C2/uk unknown
2006
- 2006-03-29 IS IS8382A patent/IS2673B/is unknown
- 2006-10-18 CY CY20061101493T patent/CY1106204T1/el unknown
- 2006-11-22 NO NO20065380A patent/NO332637B1/no not_active IP Right Cessation
2007
- 2007-01-31 HK HK07101097.3A patent/HK1095736A1/xx not_active IP Right Cessation
- 2007-02-22 JP JP2007042774A patent/JP2007137895A/ja active Pending
- 2007-11-07 GE GEAP200710360A patent/GEP20084430B/en unknown
2008
- 2008-07-08 CY CY20081100712T patent/CY1110389T1/el unknown
2010
- 2010-04-22 JP JP2010098844A patent/JP5650924B2/ja not_active Expired - Lifetime
- 2010-04-22 JP JP2010098845A patent/JP5503393B2/ja not_active Expired - Lifetime
2011
- 2011-04-25 JP JP2011096911A patent/JP5290351B2/ja not_active Expired - Lifetime
2013
- 2013-11-05 JP JP2013229622A patent/JP5717824B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
SK287430B6 (sk)	2010-09-07
HK1095736A1 (en)	2007-05-18
EP1230209A2 (de)	2002-08-14
DK1481964T3 (da)	2006-11-27
PL201422B1 (pl)	2009-04-30
EA200200511A1 (ru)	2002-10-31
KR20050100711A (ko)	2005-10-19
JP2014111589A (ja)	2014-06-19
DK1230209T3 (da)	2005-05-30
CA2389749A1 (en)	2001-05-25
SK288384B6 (sk)	2016-08-01
SI1481964T1 (sl)	2006-12-31
EP1230209B3 (de)	2011-10-05
WO2001035957A3 (de)	2001-12-27
EP1230209B1 (de)	2005-01-12
HK1045148B (zh)	2005-05-06
BR0015610B8 (pt)	2017-10-31
DE19955190A1 (de)	2001-06-21
JP2003514018A (ja)	2003-04-15
HK1045148A1 (en)	2002-11-15
JP2011148824A (ja)	2011-08-04
JP5650924B2 (ja)	2015-01-07
WO2001035957A1 (de)	2001-05-25
ATE337293T1 (de)	2006-09-15
CY1110389T1 (el)	2015-04-29
US6858650B1 (en)	2005-02-22
JP2010180243A (ja)	2010-08-19
HU227608B1 (en)	2011-09-28
IL149567A (en)	2007-08-19
EP1481964A1 (de)	2004-12-01
ATE286872T1 (de)	2005-01-15
IS2124B (is)	2006-07-14
ES2236032T7 (es)	2012-06-14
ATE395056T1 (de)	2008-05-15
NZ519230A (en)	2004-11-26
DK1690536T3 (da)	2008-09-01
KR100563149B1 (ko)	2006-03-21
EP1481964B1 (de)	2006-08-23
ZA200203315B (en)	2003-09-23
NO20022314L (no)	2002-05-15
HK1067114A1 (en)	2005-04-01
JP5290351B2 (ja)	2013-09-18
ES2303708T3 (es)	2008-08-16
KR20020059744A (ko)	2002-07-13
EA005588B1 (ru)	2005-04-28
NO332637B1 (no)	2012-11-26
KR100536095B1 (ko)	2005-12-12
CN1390194A (zh)	2003-01-08
UA77322C2 (en)	2006-11-15
ES2236032T3 (es)	2005-07-16
GEP20084430B (pl)	2008-07-25
HU228197B1 (en)	2013-01-28
JP2007137895A (ja)	2007-06-07
DE29923134U1 (de)	2000-06-29
ES2270240T3 (es)	2007-04-01
JP5503393B2 (ja)	2014-05-28
CZ20021343A3 (cs)	2002-09-11
UA73324C2 (uk)	2005-07-15
NO20022314D0 (no)	2002-05-15
IS6351A (is)	2002-04-19
HUP0204034A3 (en)	2004-12-28
SK288185B6 (sk)	2014-04-02
JP5717824B2 (ja)	2015-05-13
PT1481964E (pt)	2006-12-29
SK6572002A3 (en)	2002-12-03
BR0015610A (pt)	2002-07-30
JP4083431B2 (ja)	2008-04-30
CZ302497B6 (cs)	2011-06-15
WO2001035957A8 (de)	2001-06-21
JP2010180242A (ja)	2010-08-19
PT1230209E (pt)	2005-05-31
DE50013365D1 (de)	2006-10-05
BRPI0015610C1 (pt)	2021-05-25
DE50015163D1 (de)	2008-06-26
AU778132B2 (en)	2004-11-18
NO20065380L (no)	2002-05-15
IL149567A0 (en)	2002-11-10
CA2389749C (en)	2009-03-31
NO323920B1 (no)	2007-07-23
EP1690536A2 (de)	2006-08-16
HUP0204034A2 (hu)	2003-03-28
IS2673B (is)	2010-09-15
HU0900587D0 (en)	2009-11-30
EP1690536B1 (de)	2008-05-14
CN1215045C (zh)	2005-08-17
SI1690536T1 (sl)	2008-08-31
MXPA02004603A (es)	2004-09-10
BRPI0015610B1 (pt)	2016-04-19
DE50009239D1 (de)	2005-02-17
PT1690536E (pt)	2008-07-14
CY1106204T1 (el)	2011-06-08
AU2666701A (en)	2001-05-30
CZ302967B6 (cs)	2012-01-25
HUP0900587A3 (en)	2010-04-28
SI1230209T1 (en)	2005-06-30
EP1690536A3 (de)	2006-08-23
IS8382A (is)	2006-03-29

Publication	Publication Date	Title
HK1045148A1 (en)	2002-11-15	Stable salts of novel derivatives of 3,3-dipheylpropylamines.
AR024390A1 (es)	2002-10-02	Nuevos compuestos
DK0868424T3 (da)	2003-05-19	4-Pyrimidinyl- eller 4-pyrazinyl-piperazinyl-phenyloxazolidinonderivater, fremstilling deraf og anvendelse deraf som antibakterielle midler
SI1427720T1 (sl)	2009-08-31	3-substituirani-4-pirimidonski derivati
ES538418A0 (es)	1986-02-01	Un derivado de indol-3-carboxamida
AR029343A1 (es)	2003-06-25	USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN
DK0390114T3 (da)	1994-10-17	Undertrykkelse af syntese og udskillelse af parathyroidhormoner med vitamin D3 derivater
PT1311514E (pt)	2005-08-31	Composicoes com actividade prejudicial para a vasculatura
ATE239722T1 (de)	2003-05-15	Benzofurylpiperazine als serotonin-agonisten
MXPA02003952A (es)	2004-09-06	Derivados de imidazol como inhibidores de la fosfodieterasa vii.
HRP20010885B1 (en)	2010-07-31	Ethanesulfonyl-piperidine derivatives
NO985186L (no)	1998-11-06	Forbindelser med camptothecin-grunnstruktur, isolert fra Mappia foetida, og anvendelse derav som syntoner for nye legemidler samt som terapeutiske midler
WO2002080918A1 (fr)	2002-10-17	Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire